Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 55

Philip Morris International (PM) Stock After Hours Today (Dec. 22, 2025): Closing Price, After-Hours Move, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 23

Philip Morris International (PM) Stock After Hours Today (Dec. 22, 2025): Closing Price, After-Hours Move, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 23

Philip Morris International closed up 1.82% at $159.70 on Monday, outperforming tobacco peers and snapping a two-day slide. After-hours trading saw the stock nearly unchanged at $159.65 as of 5:51 p.m. ET, with volume at 1.22 million shares. Regular session volume was about 6.9 million shares, trading between $157.12 and $161.18. The next ex-dividend date is December 26.
23 grudnia 2025
Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

A Baltimore jury ordered Johnson & Johnson and spinoff Kenvue to pay over $1.5 billion in a talc cancer case, with J&J saying it will appeal. Kenvue shares traded at $16.98, about $1.15 below the implied $18.12 merger value based on Kimberly-Clark’s price, reflecting deal risk. The acquisition is expected to close in the second half of 2026. J&J has said it will cover Kenvue’s talc liabilities.
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics shares traded near $67.50 on Dec. 23, 2025, following strong Phase 2 data for its oral obesity drug aleniglipron, which showed up to 15.3% placebo-adjusted weight loss at 36 weeks. The company also closed a $747.5 million public offering after the trial results.
Bristol-Myers Squibb (BMY) Stock News Today: Supreme Court Bid, Drug-Pricing Deals, Dividend Boost, and 2026 Forecasts (Dec. 23, 2025)

Bristol-Myers Squibb (BMY) Stock News Today: Supreme Court Bid, Drug-Pricing Deals, Dividend Boost, and 2026 Forecasts (Dec. 23, 2025)

Bristol-Myers Squibb shares traded near $54 midday Tuesday, down about 1%, after the company and Johnson & Johnson asked the U.S. Supreme Court to review challenges to Medicare drug price negotiations. Eliquis, a key Bristol Myers drug, is set for negotiated Medicare pricing starting January 1, 2026. Guggenheim reiterated a Buy rating on BMY despite new competition for its Camzyos therapy.
Philip Morris International Stock (NYSE: PM) Today: News, Analyst Forecasts, Dividend Outlook, and What’s Driving Shares on Dec. 23, 2025

Philip Morris International Stock (NYSE: PM) Today: News, Analyst Forecasts, Dividend Outlook, and What’s Driving Shares on Dec. 23, 2025

Philip Morris International stock rose 1.4% to $161.94 as of 2:37 p.m. ET Tuesday, following a 1.82% gain Monday. Shares remain below the 52-week high of $186.69 set in June. The company secured a new $2 billion revolving credit facility and extended a €1.5 billion facility, both detailed in a Dec. 23 Form 8-K filing. No borrowings were outstanding under the replaced facility at the time of the change.
23 grudnia 2025
Eli Lilly Stock (LLY) After Hours Today (Dec. 23, 2025): What Happened After the Bell—and What to Watch Before the Market Opens Dec. 24

Eli Lilly Stock (LLY) After Hours Today (Dec. 23, 2025): What Happened After the Bell—and What to Watch Before the Market Opens Dec. 24

Eli Lilly shares closed down 0.45% at $1,071.64 on Tuesday after the FDA approved Novo Nordisk’s Wegovy pill, the first oral GLP‑1 drug for chronic weight management in the U.S. Novo shares rose on the news, while Lilly stock traded flat in after-hours. Investors focused on the competitive impact of the new oral treatment on Lilly’s obesity franchise. Trading volume reached about 2 million shares.
23 grudnia 2025
Micron Technology (MU) Stock News on Dec. 25, 2025: Record Earnings, AI Memory Boom, and Wall Street’s Latest Targets

Micron Technology (MU) Stock News on Dec. 25, 2025: Record Earnings, AI Memory Boom, and Wall Street’s Latest Targets

Micron shares closed at $286.68 on Dec. 24, 2025, after surging on strong fiscal Q1 results and an upbeat Q2 outlook. The company reported Q1 revenue of $13.64 billion and projected Q2 revenue of $18.7 billion, both well above analyst estimates. Shares have climbed over 160% in 2025 amid tight memory supply and soaring AI demand. U.S. markets were closed for Christmas Day.
Eli Lilly (LLY) Stock After Hours Today (Dec. 25, 2025): Holiday Pause, GLP‑1 Catalysts, and What to Watch Before the Market Opens Dec. 26

Eli Lilly (LLY) Stock After Hours Today (Dec. 25, 2025): Holiday Pause, GLP‑1 Catalysts, and What to Watch Before the Market Opens Dec. 26

Eli Lilly shares closed at $1,076.98 after the early NYSE close on Dec. 24, with after-hours quotes near $1,077–$1,078 in thin holiday trading. U.S. exchanges remained shut Dec. 25 for Christmas. The 52-week range stands at $623.78 to $1,111.99. Trading volume is expected to rise when markets reopen Friday, with attention on GLP-1 policy and competition.
Visa Stock (V) on Dec. 25, 2025: Where Shares Stand After the Holiday Pause — and What to Watch Before the Dec. 26 Market Open

Visa Stock (V) on Dec. 25, 2025: Where Shares Stand After the Holiday Pause — and What to Watch Before the Dec. 26 Market Open

Visa shares last traded at $355.14, up $1.76, in a shortened Dec. 24 session before U.S. markets closed for Christmas. No after-hours move occurred due to the holiday. Visa reported U.S. holiday retail spending rose 4.2% year over year, with 73% of payment volume in stores. Investors await Friday’s reopening amid fresh data and ongoing card-fee debate.
25 grudnia 2025
Mastercard (MA) Stock After Hours Today (Dec. 25, 2025): Latest News, Forecasts, and What to Know Before the Market Opens Tomorrow

Mastercard (MA) Stock After Hours Today (Dec. 25, 2025): Latest News, Forecasts, and What to Know Before the Market Opens Tomorrow

Mastercard shares last closed at $579.45 on Dec. 24 in a holiday-shortened session, with after-hours trading showing a slight dip of $0.30. U.S. markets were closed Dec. 25 for Christmas. Mastercard’s SpendingPulse data showed U.S. holiday retail sales up 3.9% year over year, topping company forecasts. Trading resumes Dec. 26.
Procter & Gamble (PG) News Today: CEO Transition Nears, Prague “Artemis” Expansion, and Wall Street Forecasts (Dec. 25, 2025)

Procter & Gamble (PG) News Today: CEO Transition Nears, Prague “Artemis” Expansion, and Wall Street Forecasts (Dec. 25, 2025)

Procter & Gamble will appoint Shailesh Jejurikar as CEO on January 1, 2026, with Jon Moeller moving to executive chairman. Swedbank AB increased its stake in the company, while Rep. Ed Case disclosed a small stock sale. Analysts adjusted price targets after a recent pullback. P&G is also advancing a new logistics and production hub near Prague.
25 grudnia 2025
Unilever PLC Stock (UL, ULVR) Outlook on Dec. 26, 2025: Magnum Spin-Off Aftermath, Analyst Targets, and What Comes Next

Unilever PLC Stock (UL, ULVR) Outlook on Dec. 26, 2025: Magnum Spin-Off Aftermath, Analyst Targets, and What Comes Next

Unilever completed the demerger of its ice cream business in December, spinning off The Magnum Ice Cream Company and consolidating shares to adjust per-share metrics. UK markets closed on December 26, leaving Unilever’s London price unchanged at 4,838.00p with zero volume; the US ADR last closed at $65.99 on December 24. Magnum debuted at €12.80 per share, with Unilever retaining a 19.9% stake.
Target Stock (TGT) Rises on Activist Stake Report as Wall Street Trades Near Record Highs: Latest News, Analyst Forecasts, and What Investors Are Watching

Target Stock (TGT) Rises on Activist Stake Report as Wall Street Trades Near Record Highs: Latest News, Analyst Forecasts, and What Investors Are Watching

Target shares rose 2.3% to $98.77 Friday after reports that Toms Capital Investment Management took a significant stake in the retailer. The move follows a year in which Target stock fell 26% amid weak sales and heavy competition. The activist investment comes ahead of a CEO transition set for February 1, 2026. TCIM has not commented on the size of its position.
26 grudnia 2025
Eli Lilly Stock (LLY) Today: GLP‑1 Price Cuts, the Obesity Pill Race, and What Investors Are Watching Into 2026

Eli Lilly Stock (LLY) Today: GLP‑1 Price Cuts, the Obesity Pill Race, and What Investors Are Watching Into 2026

Eli Lilly shares traded near $1,075 Friday afternoon, down 0.2% in thin post-Christmas trading as U.S. indexes hovered close to record highs. The stock moved between $1,068 and $1,082 amid muted volume. The NYSE and Nasdaq remained open for a regular session. Investors continue to watch Lilly’s pricing moves and its lead in obesity and diabetes treatments.
Home Depot Stock (HD) Update: Year-End Trading, 2026 Outlook, and What Investors Should Watch Before Monday’s Open

Home Depot Stock (HD) Update: Year-End Trading, 2026 Outlook, and What Investors Should Watch Before Monday’s Open

Home Depot shares closed at $349.78 Friday as U.S. stock markets ended a quiet post-Christmas session with major indexes slightly lower. The company’s 2026 outlook, released December 9, forecasts flat to modest growth in comparable sales and earnings, falling short of Wall Street expectations. Management cited continued weakness in the home improvement market. Markets reopen Monday, December 29.
27 grudnia 2025
Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria shares fell 2.34% to $57.60 Friday as the stock traded ex-dividend, with the $1.06 per share payout set for Jan. 9. Juul Labs asked an Arizona judge to block Altria and NJOY from using documents uploaded to a UCSF database, arguing the records could affect a vape patent dispute. The broader market saw light trading and finished slightly lower.
27 grudnia 2025
AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

AbbVie closed Friday at $229.98, near its 52-week high, as U.S. markets ended a quiet post-holiday session with major indexes little changed. No major AbbVie corporate news broke in the past two days, but investor analysis and institutional filings kept the stock in focus. Institutions and hedge funds hold about 70% of shares. The next regular trading session is Monday.
1 53 54 55 56 57 171
Go toTop